Table 1.

List of 20 patients with ovarian cancer selected from internal archive of Pathology Division of European Institute of Oncology, Milan

Sample ID	Histotype	Specimen type	Site	Cellularity (%)	Neoadjuvant therapy	BRCA1 status	BRCA2 status	HRD
ID_1	HGSOC	Surgical resection	Adnexa uteri	75	0	WT	WT	NEG
ID_2	HGSOC	Surgical resection	Fallopian tube	40	1	p.Ser288Argfs*10	WT	POS
ID_3	HGSOC	Biopsy	Omentum	80	0	WT	WT	POS
ID_4	HGSOC	Surgical resection	Adnexa uteri	60	0	WT	WT	POS
ID_5	HGSOC	Surgical resection	Ovary	70	0	WT	WT	NEG
ID_6	EnOC	Surgical resection	Ovary	60	0	WT	WT	NEG
ID_7	HGSOC	Surgical resection	Ovary	70	0	WT	WT	NEG
ID_8	HGSOC	Surgical resection	Ovary	60	0	WT	WT	NEG
ID_9	HGSOC	Surgical resection	Ovary	60	0	WT	WT	NEG
ID_10	HGSOC	Surgical resection	Adnexa uteri	60	1	WT	WT	NEG
ID_11	HGSOC	Biopsy	Peritoneum	80	0	WT	WT	POS
ID_12	HGSOC	Surgical resection	Ovary	80	0	WT	WT	NEG
ID_13	HGSOC	Surgical resection	Ovary	60	0	WT	WT	POS
ID_14	Mixed OC	Surgical resection	Ovary	60	0	WT	WT	NEG
ID_15	EnOC	Surgical resection	Ovary	40	0	WT	WT	NEG
ID_16	HGSOC	Surgical resection	Ovary	60	0	WT	WT	POS
ID_17	HGSOC	Surgical resection	Omentum	60	0	WT	WT	NEG
ID_18	HGSOC	Surgical resection	Peritoneum	50	1	WT	WT	NEG
ID_19	HGSOC	Surgical resection	Ovary	60	0	WT	WT	POS
ID_20	HGSOC	Surgical resection	Fallopian tube	70	0	WT	WT	NEG

BRCA, BReast CAncer associated gene; EnOC, endometrioid ovarian cancer; GSS, Genomic Scar Score; HGSOC, high-grade serous ovarian cancer; HRD, homologous recombination deficiency; NEG, negative; POS, positive; VUS, variant of uncertain significance; WT, wild-type.